FDA Inspection
Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant) – FDA Inspection, Mar 22, 2019
Record Details
This FDA Inspection record concerns Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant), with an inspection on March 22, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 22, 2019
- Product Type
- Drugs
View Company Profile
ID · 98b9736f-c6d4-4c5c-9113-69846725a990
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1084107
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 14, 2025 | Not classified | Office of Inspections and Investigations | |
| July 22, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 20, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 23, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)
- FDA Inspection 1261674 - 2025-03-14
- FDA Inspection 981968 - 2016-07-22
- FDA Inspection 866095 - 2013-12-20
- FDA Inspection 582495 - 2009-04-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.